In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year

VCRO assists clients in submitting applications for phase I/II clinical trials. With extensive practical experience in the field of cell therapy, VCRO has successfully completed 47 commissioned service cases to date, establishing ourselves as a leading brand in Taiwan’s cell therapy clinical trial arena. Choosing VCRO means gaining professional support and excellent service; we are…

min read

VCRO assists clients in submitting applications for phase I/II clinical trials. With extensive practical experience in the field of cell therapy, VCRO has successfully completed 47 commissioned service cases to date, establishing ourselves as a leading brand in Taiwan’s cell therapy clinical trial arena.

Choosing VCRO means gaining professional support and excellent service; we are committed to helping every client succeed on their journey in cell therapy.

If you need our services, feel free to contact us anytime via our official Facebook page or Line official account for interaction with our team!

News Link: https://news.gbimonthly.com/tw/article/show.php?num=67817